Content |
Richter-Helm BioTec is a microbiological contract company headquartered in northern Germany.
Performance indicators
2024: Annual revenue - around €60m
The company's annual income is about 60 million euros. RHB is expected to complete a major investment deal worth around €100m in 2024 to expand production and develop the range of services for pharmaceutical companies.
As of March 2024, Richter-Helm BioTec has three manufacturing sites with more than 300 employees.
History
2024: Purchase of a 50% stake in Richter-Helm BioTec by Gedeon Richter
Gedeon Richter has signed an agreement with German stock corporation HELM AG to buy a 50% stake in Richter-Helm BioTec (RHT) and a 30% stake in Richter-Helm BioLogics (RHB), making Gedeon Richter the 100% owner of both companies. This was announced to Zdrav.Expert on March 14, 2024 by representatives of Gedeon Richter. Read more here.
Under the terms of the agreement, Gedeon Richter will pay €40.6 million for HELM's stake in Richter-Helm BioLogics and €71.8 million for its stake in Richter-Helm BioTec.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |